RH Strategic Consulting Logo
    RH Strategic Consulting

    Privacy Policy

    Your privacy is important to us. This policy outlines how RH Strategic Consulting collects, uses, and protects your information.

    Information We Collect

    We collect information you provide directly to us, such as when you create an account, use our ROI calculator, contact us for support, or sign up for our newsletter.

    This may include your name, email address, company information, and any other information you choose to provide.

    How We Use Your Information

    We use the information we collect to:

    • Provide, maintain, and improve our services
    • Process transactions and send related information
    • Send technical notices, updates, security alerts, and support messages
    • Respond to your comments, questions, and customer service requests
    • Communicate with you about products, services, and events

    ChemoHarmony Health Application

    RH Strategic Consulting, LLC develops and operates ChemoHarmony (https://chemoharmony.com), a wellness tracking application designed to support individuals undergoing chemotherapy treatment.

    Data Collected by ChemoHarmony

    ChemoHarmony collects health-related data including:

    • Cancer type and stage
    • Treatment regimen details
    • Daily symptom check-ins (mood, sleep quality, symptoms)
    • Medication names, dosages, and adherence
    • Emergency contact information
    • AI companion chat messages

    Apple Health (HealthKit) Integration

    On iOS devices, ChemoHarmony offers optional Apple Health (HealthKit) integration that reads step count, weight, heart rate, blood oxygen saturation, sleep analysis, and body temperature data. This integration is entirely optional and user-initiated.

    HealthKit data is stored securely and is never used for advertising, marketing, or data mining purposes. HealthKit data is never sold or shared with third parties.

    Security

    All ChemoHarmony health data is encrypted in transit using TLS and encrypted at rest, with bcrypt-hashed passwords and JWT-based session management.

    HIPAA Notice

    ChemoHarmony is not a HIPAA-covered entity but voluntarily implements security practices aligned with industry standards for protecting health-related data.

    Data Sharing

    ChemoHarmony does not sell, rent, or trade personal health information to third parties.

    Your Rights

    Users can export all their data in JSON format and can permanently delete their account and all associated data at any time within the application.

    ChemoHarmony's complete privacy policy is available at https://chemoharmony.com/privacy. For ChemoHarmony-specific privacy inquiries, contact privacy@chemoharmony.com.

    Cookies and Tracking

    We use cookies and similar tracking technologies to collect and track information about your use of our website and to improve your experience.

    You can control cookies through your browser settings. However, disabling cookies may affect the functionality of our website.

    Data Security

    We take reasonable measures to protect your personal information from loss, theft, misuse, and unauthorized access, disclosure, alteration, and destruction.

    However, no internet or electronic storage system is 100% secure, so we cannot guarantee absolute security.

    Compliance

    RH Strategic Consulting is committed to complying with applicable data protection laws, including GDPR, CCPA, and other relevant privacy regulations.

    Health data collected through ChemoHarmony is subject to additional protections as described in the ChemoHarmony section above and in ChemoHarmony's dedicated privacy policy at https://chemoharmony.com/privacy.

    If you have any questions about this Privacy Policy or our data practices, please contact us at privacy@rhconsulting.ai.

    Updates to This Policy

    We may update this Privacy Policy from time to time. We will notify you of any changes by posting the new Privacy Policy on this page and updating the "Last Updated" date.

    Last Updated: February 19, 2026